8 recruiting, 2 completed. 7 Phase 1, 6 Phase 2, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Recruiting 6, Completed 1 |
| Phase 2 | 6 | Recruiting 5, Completed 1 |
| Early Phase 1 | 1 | Recruiting 1 |
Follow Panitumumab-IRDye800: new trials by email Literature Review of Panitumumab-IRDye800 trials Research Report on Panitumumab-IRDye800
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures Panitumumab-IRDye800, Pinpoint-IR9000 endoscopic/handheld device, Explorer Air camera - Brain Tumor | Phase 1 / Phase 2 | Recruiting | Stanford University | 12 | 2026-12-01 | 2026-09-29 |
| Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell Carcinoma Panitumumab-IRDye800, [18F]NOTA-ABY-030 - HNSCC,Larynx, Pharynx and Oral Cavity, Squamous Cell Carcinoma | Phase 1 | Recruiting | Vanderbilt-Ingram Cancer Center | 30 | 2026-10-01 | 2026-10-19 |
| Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures Panitumumab-IRDye800 - Meningioma, Glioblastoma | Early Phase 1 | Recruiting | Eben Rosenthal | 30 | 2026-07-07 | 2026-10-16 |
| Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer Panitumumab-IRDye800, Indium In 111 Panitumumab, Single Photon Emission Computed Tomography - Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma | Phase 1 | Recruiting | Vanderbilt-Ingram Cancer Center | 40 | 2023-10-03 | 2025-10-03 |
| Phase II Panitumumab-IRDye800 in Head & Neck Cancer Panitumumab-IRDye800 - Head and Neck Cancer | Phase 2 | Recruiting | University of Alabama at Birmingham | 25 | 2021-04-02 | 2025-12-24 |
| Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer Panitumumab-IRDye800, Lymphoseek - Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Phase 2 | Completed | Eben Rosenthal | 3 | 2019-08-01 | 2022-11-10 |
| Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer Panitumumab-IRDye800, 89-Zirconium (Zr-89) Panitumumab, Pinpoint IR IR9000 fluorescence imaging system (FIS) - Squamous Cell Carcinoma of the Head and Neck, Carcinoma of the Head and Neck | Phase 1 | Completed | Andrei Iagaru | 14 | 2019-01-07 | 2023-05-19 |
| Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery Near-Infrared Fluorescence Imaging, Panitumumab-IRDye800, Pharmacokinetic Study - Lung Carcinoma, Metastatic Malignant Neoplasm in the Lung | Phase 1 / Phase 2 | Recruiting | Stanford University | 30 | 2018-07-19 | 2026-10-05 |
| Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery Near-Infrared Fluorescence Imaging, Panitumumab, Panitumumab-IRDye800 - Malignant Brain Neoplasm, Malignant Glioma | Phase 1 / Phase 2 | Recruiting | Stanford University | 46 | 2018-05-16 | 2026-06-29 |
| Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery Fluorescence Imaging, Panitumumab, Panitumumab-IRDye800 - Pancreatic Adenocarcinoma | Phase 1 / Phase 2 | Recruiting | George Poultsides | 27 | 2018-02-07 | 2026-03-17 |
Head and Neck Neoplasms (4) · Squamous Cell Carcinoma of Head and Neck (4) · Brain Neoplasms (3) · Carcinoma, Squamous Cell (1) · Glioblastoma (1) · Glioma (1) · Laryngeal Diseases (1) · Lung Neoplasms (1) · Meningioma (1) · Neoplasms (1) · Neuroma, Acoustic (1) · Pituitary Neoplasms (1)
Stanford University (3) · Eben Rosenthal (2) · Vanderbilt-Ingram Cancer Center (2) · Andrei Iagaru (1) · George Poultsides (1) · University of Alabama at Birmingham (1)
United States (10)
Andrei Iagaru, MD (1) · Anthony Morlandt, DDS MD (1) · Eben Rosenthal, MD (1) · Fred M Baik (1) · George Poultsides (1) · Laura Prolo, MD (1) · Lindsay Moore, MD (1) · Natalie Lui (1) · Peter Morone, MD (1)
R01CA190306 (4), P30CA124435 (2), R01CA266233 (1)